Works matching IS 00071048 AND DT 2023 AND VI 202 AND IP 2
Results: 33
Expanding the clinical phenotype of FADD deficiency with a novel mutation and its role in Fas‐mediated apoptotic pathway.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. e11, doi. 10.1111/bjh.18871
- By:
- Publication type:
- Article
Navigating through the haemostatic paradox in kidney failure: A practical overview.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 230, doi. 10.1111/bjh.18903
- By:
- Publication type:
- Article
Real‐world management of small lymphocytic lymphoma as chronic lymphocytic leukaemia versus an indolent non‐Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 445, doi. 10.1111/bjh.18879
- By:
- Publication type:
- Article
Long non‐coding RNAs associated with transcriptomic signatures and treatment outcome in diffuse large B‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 440, doi. 10.1111/bjh.18870
- By:
- Publication type:
- Article
Is there a representative quality‐of‐life questionnaire for patients with AL amyloidosis?—systematic literature review.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 289, doi. 10.1111/bjh.18860
- By:
- Publication type:
- Article
Clinical approaches for integrating machine learning for patients with lymphoma: Current strategies and future perspectives.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 219, doi. 10.1111/bjh.18861
- By:
- Publication type:
- Article
Tandem versus single haematopoietic stem cell transplant and BV maintenance in relapsed/refractory Hodgkin lymphoma: A matched cohort analysis from the LYSA.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 379, doi. 10.1111/bjh.18859
- By:
- Publication type:
- Article
Response to Knight and Nelson‐Piercy 'Clarity of guidelines concerning the care of pregnant women is lost by the use of de‐sexed language'.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 438, doi. 10.1111/bjh.18858
- By:
- Publication type:
- Article
Prognostic impact of complex and/or monosomal karyotypes in post‐transplant poor cytogenetic acute myeloid leukaemia: A quantitative approach.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 356, doi. 10.1111/bjh.18855
- By:
- Publication type:
- Article
Clarity of guidelines concerning the care of pregnant women is lost by the use of de‐sexed language.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 437, doi. 10.1111/bjh.18857
- By:
- Publication type:
- Article
Daratumumab for refractory immune‐mediated thrombotic thrombocytopenic purpura.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 429, doi. 10.1111/bjh.18854
- By:
- Publication type:
- Article
Combination of azacitidine, venetoclax and ruxolitinib in blast phase myeloproliferative neoplasms.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 284, doi. 10.1111/bjh.18853
- By:
- Publication type:
- Article
The prognostic impact of IKZF1 deletions and UKALL genetic classifiers in paediatric B‐cell precursor acute lymphoblastic leukaemia treated according to NOPHO 2008 protocols.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 384, doi. 10.1111/bjh.18852
- By:
- Publication type:
- Article
Germline Neurofibromin 1 mutation enhances the anti‐tumour immune response and decreases juvenile myelomonocytic leukaemia tumourigenicity.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 328, doi. 10.1111/bjh.18851
- By:
- Publication type:
- Article
Paraneoplastic pemphigus uncovers distinct clinical and biological phenotypes of western unicentric Castleman disease.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 267, doi. 10.1111/bjh.18847
- By:
- Publication type:
- Article
The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 279, doi. 10.1111/bjh.18850
- By:
- Publication type:
- Article
Outcomes of allogeneic or autologous stem cell transplantation followed by maintenance chemotherapy in adult patient with B‐ALL in CR1 with no detectable minimal residual disease.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 369, doi. 10.1111/bjh.18846
- By:
- Publication type:
- Article
Interferon alpha‐2 treatment reduces circulating neutrophil extracellular trap levels in myeloproliferative neoplasms.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 318, doi. 10.1111/bjh.18845
- By:
- Publication type:
- Article
Sustained response off treatment in eltrombopag for children with persistent/chronic primary immune thrombocytopenia: A multicentre observational retrospective study in China.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 422, doi. 10.1111/bjh.18842
- By:
- Publication type:
- Article
HAX1‐related congenital neutropenia: Long‐term observation in paediatric and adult patients enrolled in the European branch of the Severe Chronic Neutropenia International Registry (SCNIR).
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 393, doi. 10.1111/bjh.18840
- By:
- Publication type:
- Article
Leukaemic blasts in a urine specimen in acute myeloid leukaemia with CEBPA mutation.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 212, doi. 10.1111/bjh.18838
- By:
- Publication type:
- Article
Predicting short‐term and long‐term mortalities from sepsis in patients who receive allogeneic haematopoietic stem cell transplantation.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 344, doi. 10.1111/bjh.18835
- By:
- Publication type:
- Article
Cannibalism in an ETV6::RUNX1 paediatric B acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 211, doi. 10.1111/bjh.18836
- By:
- Publication type:
- Article
Molecular‐defined clonal evolution in patients with classical myeloproliferative neoplasms.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 308, doi. 10.1111/bjh.18834
- By:
- Publication type:
- Article
Risk factors for CAR‐T cell manufacturing failure among DLBCL patients: A nationwide survey in Japan.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 256, doi. 10.1111/bjh.18831
- By:
- Publication type:
- Article
Real‐world evidence of the safety and survival with CD19 CAR‐T cell therapy for relapsed/refractory solid organ transplant‐related PTLD.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 248, doi. 10.1111/bjh.18828
- By:
- Publication type:
- Article
Anti‐PD‐1 therapy can possibly reverse CAR T cells exhaustion in DLBCL.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 217, doi. 10.1111/bjh.18797
- By:
- Publication type:
- Article
Antinuclear antibodies in childhood immune thrombocytopaenia: An increased risk for development of autoimmune disorders?
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 215, doi. 10.1111/bjh.18795
- By:
- Publication type:
- Article
What drives CAR‐T emergent cytopenia?
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 213, doi. 10.1111/bjh.18790
- By:
- Publication type:
- Article
Bone marrow microenvironment disruption and sustained inflammation with prolonged haematologic toxicity after CAR T‐cell therapy.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 294, doi. 10.1111/bjh.18747
- By:
- Publication type:
- Article
The effect of antinuclear antibody titre and its variation on outcomes in children with primary immune thrombocytopenia.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 412, doi. 10.1111/bjh.18732
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 207, doi. 10.1111/bjh.18263
- Publication type:
- Article
Safety and efficacy of nivolumab in patients who failed to achieve a complete remission after CD19‐directed CAR T‐cell therapy in diffuse large B cell lymphoma.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 434, doi. 10.1111/bjh.18775
- By:
- Publication type:
- Article